<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Genetics of inclusion-body myositis</title>
			</titleStmt>
			<publicationStmt>
				<publisher>Wiley</publisher>
				<availability status="unknown"><p>Copyright Wiley</p>
				</availability>
				<date type="published" when="2007-03-15">15 March 2007</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><roleName>MBBS</roleName><forename type="first">M</forename><surname>Needham</surname></persName>
							<email>needhm01@student.uwa.edu.au</email>
							<affiliation key="aff0">
								<orgName type="department">Centre for Neuromuscular and Neurological Disorders</orgName>
								<orgName type="institution">University of Western Australia</orgName>
								<address>
									<addrLine>Level 4, A Block</addrLine>
									<region>Queen</region>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Elizabeth II Medical Centre</orgName>
								<address>
									<postCode>6009</postCode>
									<settlement>Nedlands</settlement>
									<region>Western</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">F</forename><forename type="middle">L</forename><surname>Mastaglia</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Centre for Neuromuscular and Neurological Disorders</orgName>
								<orgName type="institution">University of Western Australia</orgName>
								<address>
									<addrLine>Level 4, A Block</addrLine>
									<region>Queen</region>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution">Elizabeth II Medical Centre</orgName>
								<address>
									<postCode>6009</postCode>
									<settlement>Nedlands</settlement>
									<region>Western</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">M</forename><forename type="middle">J</forename><surname>Garlepp</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">School of Pharmacy and Western Australian Biomedical Research Institute</orgName>
								<orgName type="institution">Curtin University of Technology</orgName>
								<address>
									<settlement>Perth</settlement>
									<region>Western Australia</region>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Genetics of inclusion-body myositis</title>
					</analytic>
					<monogr>
						<title level="j" type="main">Muscle &amp; Nerve</title>
						<title level="j" type="abbrev">Muscle Nerve</title>
						<idno type="ISSN">0148-639X</idno>
						<idno type="eISSN">1097-4598</idno>
						<imprint>
							<publisher>Wiley</publisher>
							<biblScope unit="volume">35</biblScope>
							<biblScope unit="issue">5</biblScope>
							<biblScope unit="page" from="549" to="561"/>
							<date type="published" when="2007-03-15">15 March 2007</date>
						</imprint>
					</monogr>
					<idno type="MD5">AF7304BFE6A51E538E03FC5C742FFB37</idno>
					<idno type="DOI">10.1002/mus.20766</idno>
					<note type="submission">Accepted 28 January 2007</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2" ident="GROBID" when="2023-03-30T18:12+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>COX, cytochrome c oxidase</term>
					<term>DMRV, distal myopathy with rimmed vacuoles</term>
					<term>ER, endoplasmic reticulum</term>
					<term>fIBM, familial inclusion-body myositis</term>
					<term>hIBM, hereditary inclusion-body myopathy</term>
					<term>HLA, human leukocyte antigen</term>
					<term>IBMPFD, IBM associated with Paget&apos;s disease and frontotemporal dementia</term>
					<term>IL-1, interleukin 1</term>
					<term>IFN-␥, interferon gamma</term>
					<term>LAMA2, laminin ␣2</term>
					<term>LGMD, limb-girdle muscular dystrophy</term>
					<term>MHC, major histocompatibility complex</term>
					<term>OPMD, oculopharyngeal muscular dystrophy</term>
					<term>PABN, polyadenylate-binding protein</term>
					<term>RRF, ragged-red fibers</term>
					<term>sIBM, sporadic inclusion-body myositis</term>
					<term>TCR, T-cell receptor</term>
					<term>TNF-␣, tumor necrosis factor alpha</term>
					<term>VCP, valosin-containing protein genes</term>
					<term>genetics</term>
					<term>inclusion-body myopathy</term>
					<term>inclusion-body myositis</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Sporadic inclusion-body myositis (sIBM) is the most common acquired muscle disease in Caucasians over the age of 50 years. Pathologically it is marked by inflammatory, degenerative, and mitochondrial changes that interact in a yet-unknown way to cause progressive muscle degeneration and weakness. The cause of the disease is unknown, but it is thought to involve a complex interplay between environmental factors, genetic susceptibility, and aging. The strongest evidence for genetic susceptibility comes from studies of the major histocompatibility complex (MHC), where different combinations of alleles have been associated with sIBM in different ethnic groups. The rare occurrence of familial cases of inclusionbody myositis (fIBM) adds additional evidence for genetic susceptibility. Other candidate genes such as those encoding some of the proteins accumulating in muscle fibers have been investigated, with negative results. The increased understanding of related disorders, the hereditary inclusion-body myopathies (hIBM), may also provide clues to the underlying pathogenesis of sIBM, but to date there is no indication that the genes responsible for these conditions are involved in sIBM. This review summarizes current understanding of the contribution of genetic susceptibility factors to the development of sIBM.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>(TNF-␣), and interferon gamma (IFN-␥) could be an early upstream pathogenic event causing both the inflammatory and degenerative components of sIBM, as hypothesized by Dalakas in 2006. <ref type="bibr" target="#b30">31</ref> Proinflammatory cytokines are very effective inducers of MHC class I expression in human myotubes. <ref type="bibr" target="#b85">86</ref> It has been suggested that MHC class I expression exerts a stressor effect on the endoplasmic reticulum (ER) causing NFB upregulation, <ref type="bibr" target="#b91">92</ref> leading to further enhancement of MHC class I antigen assembly and cell membrane expression, <ref type="bibr" target="#b91">92</ref> which may in turn lead to a self-sustaining T-cell response. <ref type="bibr" target="#b90">91</ref> Proinflammatory cytokines (particularly IL-1), <ref type="bibr" target="#b48">49,</ref><ref type="bibr" target="#b54">55</ref> as well as NFB <ref type="bibr" target="#b53">54</ref> have been shown to increase APP transcription, which results in increased ␤-amyloid production. This could then cascade, causing a cycle of ER stress, proteasome dysfunction, and protein accumulation.</p><p>On the other hand, it is possible that ␤-amyloid accumulation (due to overproduction or abnormalities in processing in APP) is an early upstream event as proposed by Askanas and Engel, <ref type="bibr" target="#b19">20</ref> causing ER stress, oxidative stress, and a T-cell response to peptides derived from the accumulating proteins. This relationship between the inflammatory and degenerative processes is supported by observations that in sIBM muscles there is a linear relationship between the mRNA level of cytokines and chemokines, and that of APP, tau, and ubiquitin. <ref type="bibr" target="#b110">111</ref> Genes encoding APP, tau, ApoE, and oxidative stress proteins are overexpressed in sIBM, but as with their respective proteins, these genes are also known to be overexpressed in polymyositis, hereditary inclusion-body myopathy (hIBM), and other myopathies. <ref type="bibr" target="#b51">52,</ref><ref type="bibr" target="#b105">106</ref> The ultimate cause of the postulated proinflammatory cytokine expression or ␤-amyloid overproduction is still unknown.</p><p>Multiple genetic factors may contribute to the development and progression of sIBM. The prevalence of sIBM differs between different ethnic groups, with a seemingly reduced incidence in Korean, Mesoamerican Mestizos, Polish, <ref type="bibr" target="#b113">114</ref> Middle Eastern, and Southern Mediterranean populations as compared with North American Caucasians, Dutch, and Australians, in whom prevalence figures of between 4.9 -9.3 per million have been reported. <ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b39">40,</ref><ref type="bibr" target="#b99">100</ref> These differences in prevalence may be due to differences in genetic makeup of different racial groups, differences in environmental factors, or a combination of both. Particular genetic predisposing factors may determine the effects of different inducing agents, which may vary in their geographical distribution.</p><p>When investigating genetic associations with presumed autoimmune diseases, including the inflam-matory myopathies, the most commonly considered genes are those that encode immunologically relevant proteins, particularly those in the MHC, the T-cell receptor (TCR) genes, and the immunoglobulin genes. So far the search for susceptibility genes in sIBM has been based solely on candidate gene studies, as the rarity of the condition has precluded the use of more robust genetic methods such as twin studies, whole genome screening, and transmission disequilibrium testing. Multiple case reports of two or more siblings being affected in the one family, and rare reports of affected twins 2 clearly suggest a familial predisposition for developing sIBM. So far, MHC associations provide the strongest evidence for a genetic component in sIBM. Unique MHC associations are seen with different racial groups and may reflect different T-cell receptor repertoires or different inducing agents. Identifying the susceptibility gene in the MHC will be extremely important in helping to elucidate the pathogenesis of sIBM. Although the MHC contains many genes that influence immune function, it also contains a range of other genes that encode proteins involved in a number of basic cellular and regulatory functions. It will be of great interest to determine whether this MHCassociated susceptibility gene is involved in determining the immune and inflammatory component of the disease, or is involved in other cellular functions that influence muscle degeneration.</p><p>In addition to MHC associations, polymorphisms and mutations in genes encoding the deposited proteins including APP, <ref type="bibr" target="#b114">115</ref> prion protein, <ref type="bibr" target="#b97">98</ref> ApoE, <ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b47">48,</ref><ref type="bibr" target="#b55">56</ref> and ␣1ACT, <ref type="bibr" target="#b49">50</ref> as well as multiple mitochondrial mutations, <ref type="bibr" target="#b61">62,</ref><ref type="bibr" target="#b95">96</ref> have all been investigated. Clues for further candidate gene studies are arising from the progress that has been made over the last decade in identifying genes associated with hIBM and other vacuolar myopathies that have features similar to sIBM (see below), as well as gene expression profiling studies. <ref type="bibr" target="#b51">52</ref> The identification of susceptibility genes is fundamental to elucidating the pathogenesis of sIBM and will provide clues to the development of targeted therapies.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>HEREDITARY INCLUSION-BODY MYOPATHIES</head><p>Hereditary IBM is a term introduced in 1993 <ref type="bibr" target="#b9">10</ref> to describe a group of autosomal-dominant (AD) or autosomal-recessive (AR) adult-onset muscle disorders, which have variable clinical phenotypes but have a number of pathological features resembling sIBM, including rimmed vacuoles and intracytoplasmic and intranuclear tubulofilamentous inclusions. Clinically there is an earlier age of onset and the rarity of inflammatory changes and negative MHC class I staining on the muscle biopsy help distinguish these forms from sIBM. <ref type="bibr" target="#b52">53,</ref><ref type="bibr" target="#b115">116</ref> Autosomal-Recessive hIBM. Several different types of hIBM have been described under various names in different ethnic groups. <ref type="bibr" target="#b37">38</ref> The prototypic AR form (IBM2; OMIM 600737) first described in Iranian Jews by Argov and Yarom 3 was characterized in Jews of Persian descent as a quadriceps-sparing myopathy. Genomic linkage was established among the Iranian Jews in 1996, <ref type="bibr" target="#b87">88</ref> the genomic susceptibility region was subsequently narrowed to 9p13, <ref type="bibr" target="#b35">36</ref> and finally a UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase (GNE) founder gene mutation (M712T) was found in Persian Jews. <ref type="bibr" target="#b36">37</ref> This discovery led to confirmation that the Japanese muscle disease previously called Nonaka myopathy or distal myopathy with rimmed vacuoles (DMRV) is the same disease when a variety of homozygous or compoundheterozygous mutations were described in either the epimerase or kinase domains of the GNE gene. <ref type="bibr" target="#b67">68</ref> Many different GNE missense mutations have now been described in various ethnic groups, including people from Italy, the US, Germany, Ireland, Bahamas, Tunisia, and East India. <ref type="bibr" target="#b37">38</ref> A number of variations in phenotypes have also been described. These include forms in which the quadriceps are involved, <ref type="bibr" target="#b5">6</ref> as well as pathological differences including the presence of muscle inflammation in rare cases. <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b74">75,</ref><ref type="bibr" target="#b123">124</ref> It has been hypothesized that these differences are mutation specific. <ref type="bibr" target="#b32">33</ref> GNE is a bifunctional enzyme that catalyzes the first two steps in the synthesis of N-acetylneuraminic (sialic) acid. GNE consists of two functional domains: a UDP-GlcNAc-2-epimerase domain and a ManNAc kinase domain. In hIBM, mutations in both domains have been reported, <ref type="bibr" target="#b37">38</ref> resulting in reduction in both enzymatic activities <ref type="bibr" target="#b98">99</ref> that may lead to a disturbance of sialic acid metabolism. <ref type="bibr" target="#b50">51</ref> Nishino et al. <ref type="bibr" target="#b93">94</ref> showed that the loss of function in the GNE enzyme can be recovered by adding GNE metabolites such as ManNAc and NeuAc. Sialic acid is considered to play important roles in several cellular processes including cellular adhesion, <ref type="bibr" target="#b98">99</ref> formation of or marking recognition sites for toxins and other pathogenic agents, stabilization of glycoprotein structures, signal transduction, and cell-mediated immune responses. <ref type="bibr" target="#b26">27</ref> Whether hyposialation of glycoproteins in skeletal muscle plays a role in the pathogenesis of hIBM, and why mutations in GNE affect predominately the skeletal muscle, remain to be determined.</p><p>To date, more than 40 different mutations in the GNE gene have been reported to cause AR hIBM. <ref type="bibr" target="#b98">99</ref> Interestingly, homozygous missense GNE mutations have been reported <ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b93">94</ref> in some clinically unaffected individuals, indicating that other factors play a role in the pathogenesis of disease. Such factors, which are not yet elucidated, seem to be important in the clinical expression of disease in all patients; although the gene defect is present from conception, it may not result in clinically manifest disease until the third or fourth decade. Mutations in GNE have not been found in cases of sIBM, <ref type="bibr" target="#b120">121</ref> but the possibility that other variations in the gene may influence susceptibility to sIBM has not been investigated.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>AR hIBM without GNE Mutation.</head><p>There have been case reports of families with AR IBM not associated with a GNE gene mutation. Cole et al. <ref type="bibr" target="#b27">28</ref> in 1988 described an AR familial proximal early-onset quadriceps-involving myopathy with histological changes resembling IBM and an asymptomatic periventricular leukoencephalopathy, which was not linked to 9p1-q1. <ref type="bibr" target="#b3">4</ref> A similar case was reported by Di Blasi et al. <ref type="bibr" target="#b34">35</ref> These authors described a 29-year-old man with a leukoencephalopathy and a vacuolar myopathy resembling IBM that was due to a partial laminin ␣2 chain deficiency secondary to two novel LAMA2 gene mutations.</p><p>Autosomal-Dominant Forms. AD forms of hIBM have also been described (IBM1 and IBM3; OMIM 601419 and 605637). IBM3 was previously known as "AD myopathy with congenital joint contractures, ophthalmoplegia and rimmed vacuoles." It was reported in 1998 by Darin et al., <ref type="bibr" target="#b31">32</ref> and subsequently mapped to 17p13, <ref type="bibr" target="#b82">83</ref> and found to be due to a mutation in the myosin heavy chain IIa (MHCIIa) gene <ref type="bibr" target="#b83">84</ref> (Glu706-Lys). In this condition only minor abnormalities are seen in childhood and adolescence, from 30 -50 years of age; however, there is progressive limb-muscle weakness, with atrophy being most prominent in the pectoralis and quadriceps muscles.</p><p>Another AD IBM associated with Paget's disease and frontotemporal dementia (IBMPFD) has been described in four American families <ref type="bibr" target="#b73">74</ref> and in an Austrian family, <ref type="bibr" target="#b57">58</ref> and has been linked to a mutation in the valosin-containing protein (VCP) gene on chromosome 9p13-p12. VCP is a member of the "ATPases associated with a variety of activities" (AAA-ATPase) family, a group of enzymatic molecular chaperones that have been associated with a variety of cellular processes such as ubiquitin-proteasomemediated degradation, membrane fusion, apoptosis, and cell-cycle control. <ref type="bibr" target="#b57">58</ref> A number of independent studies have confirmed that disruption of a specific function of VCP leads to inclusion-body formation and ultimately cell death. <ref type="bibr" target="#b122">123</ref> There are other AD-inherited vacuolar myopathies that have been put into this category. These include most of the distal myopathies, including Welander's distal myopathy (OMIM 604454), which is linked to chromosome 2p13, and tibial muscular dystrophy (Udd myopathy; OMIM 600334), which is due to mutations in the titin gene (2q31).</p><p>Other Rimmed Vacuolar Myopathies. The differential diagnosis when rimmed vacuoles are present in muscle is wide and includes all of the above conditions, as well as oculopharyngeal muscular dystrophy (OPMD, polyadenylate-binding protein nuclear 1 (PABPN1) mutations), X-linked Emery-Dreifuss muscular dystrophy <ref type="bibr" target="#b43">44</ref> (emerin gene mutations), LGMD2G (telethonin mutations), LGMD1A (myotilin mutations), LGMD1G (Chr 4p21), and rigid spine syndrome. In addition, rimmed vacuoles may even be found in chronic neurogenic conditions such as old poliomyelitis <ref type="bibr" target="#b42">43,</ref><ref type="bibr" target="#b112">113</ref> or chronic spinal muscular atrophy. <ref type="bibr" target="#b44">45</ref> However, the clinical presentation, as well as the content of the vacuoles, helps to distinguish these conditions. Askanas and Engel <ref type="bibr" target="#b17">18</ref> reported that the unusual constellation of proteins found in the inclusions of sIBM and hIBM do not occur in either the vacuolated or nonvacuolated fibers of other muscle diseases except OPMD. However, there is extensive overlap, as the intracellular accumulation of amyloid-related proteins, APP, phosphorylated tau, presenilin-1, apolipoprotein-E, ␥-tubulin, clusterin, ␣-synuclein, gelsolin, oxidative stress proteins, and all the components of the catalytic core of the proteasomes have been found to be equally expressed in sIBM and the myofibrillar myopathies. <ref type="bibr" target="#b40">41,</ref><ref type="bibr" target="#b41">42</ref> Therefore, different etiologies may lead to a common downstream pathogenic cascade that is responsible for the muscle degeneration, similar to the concept that in Alzheimer's disease different genetic factors and unknown causes of sporadic Alzheimer's disease lead to the same pathological findings.</p><p>Thus, the group of diseases encompassed by the term hIBM is heterogeneous, both clinically and genetically, and may or may not provide clues to the underlying etiology and pathogenesis of sIBM.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>FAMILIAL INCLUSION-BODY MYOSITIS (fIBM)</head><p>Familial IBM is associated with the typical clinical and histopathological findings that are seen in sIBM, but occurs in siblings in the same generation or, rarely, with a dominant pattern of transmission. <ref type="bibr" target="#b84">85,</ref><ref type="bibr" target="#b92">93</ref> It differs from hIBM with respect to the age of onset, the selective pattern of clinical muscle involvement (the quadriceps and long finger flexor muscles as seen in sIBM <ref type="bibr" target="#b116">117</ref> ), and typical histological features. <ref type="bibr" target="#b107">108</ref> It has been described in several families, <ref type="bibr" target="#b58">59,</ref><ref type="bibr" target="#b107">108,</ref><ref type="bibr" target="#b116">117,</ref><ref type="bibr" target="#b118">119</ref> and in some families the disease is associated with particular human leukocyte antigen (HLA) alleles. In particular, fIBM has been associated with DR3(DRB1*0301/ 0302) <ref type="bibr" target="#b107">108,</ref><ref type="bibr" target="#b116">117</ref> and DR15(2)/4 (DRB1*1502/0405). <ref type="bibr" target="#b118">119</ref> This association with DR3 indicates that fIBM is not only phenotypically and histologically identical to sIBM, but is also associated with similar genetic markers, raising the possibility that the two subsets of IBM share the same inherited determinants of susceptibility to the inflammatory process. <ref type="bibr" target="#b116">117</ref> The familial occurrence of such a rare disease highlights the importance of genetic predisposition in the etiology and pathogenesis of sIBM.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MAJOR HISTOCOMPATIBILITY COMPLEX</head><p>The MHC is densely packed with immunologically important genes. The extended MHC has been associated with over 100 diseases, most of which are immune-mediated. This is not surprising, given that 28% of the 252 transcripts encoded by genes in the extended MHC are immune-related. <ref type="bibr" target="#b60">61</ref> The association of polymorphic variants of genes within the MHC with autoimmune disease often relates directly to the important role that MHC molecules play in regulating the types and degree of immune responses to environmental agents, T-cell receptor repertoire development, and peripheral tolerance to self antigens. <ref type="bibr" target="#b94">95</ref> It has been speculated that dysregulation of MHC-mediated immunological recognition events contributes to a breakdown of self-tolerance and the resultant development of autoimmune pathology. However, the MHC also contains many genes whose function is not related to the immune system, and altered function of these genes may lead to disease by nonimmunological mechanisms (e.g., 21-hydroxylase deficiency <ref type="bibr" target="#b81">82</ref> ). Detailed intra-MHC mapping is often required to identify the causative gene once an association with the MHC has been described.</p><p>A hallmark of the MHC is the existence of strong linkage disequilibrium, which is manifest in the concurrence of certain alleles at a number of loci within the MHC more frequently than expected by chance. This strong linkage can facilitate the identification of indirect disease associations but sometimes confounds the identification of causative genes. This concurrence of certain combinations of alleles on specific haplotypes allows the definition of a series of ancestral haplotypes (AH) that have been conserved during evolution and occur commonly throughout the population. <ref type="bibr" target="#b33">34</ref> The concept of the AH predicts that haplotypes from unrelated people who share certain marker alleles (at loci such as HLA-B and HLA-DR) will be identical for the alleles at loci between those markers. <ref type="bibr" target="#b71">72</ref> Although AHs are highly conserved, recombination between different AHs has occurred during evolution so that the presence of varying lengths of individual AH on unrelated haplotypes is not uncommon. These recombinant AHs can be used to localize the gene or genes in the MHC associated with a particular disease. <ref type="bibr" target="#b102">103</ref> Diseases that have been demonstrated to have MHC associations include type 1 diabetes, ankylosing spondylitis, Graves' disease, Addison's disease, and myasthenia gravis. In some cases the MHC association is strongest with an individual allele (such as HLA-B27 in ankylosing spondylitis); in other cases the associations are with alleles or combinations of alleles that form part of a conserved AH. In particular, the AH characterized by HLA-A*01, -B*0801, -DRB1*0301, -DQB1*0201, -DQA1*05 (referred to as the 8.1 AH), is considered the "autoimmune haplotype" in Caucasians because it has been associated with many different autoimmune diseases. <ref type="bibr" target="#b102">103</ref> The 8.1 AH is common in Caucasian populations, particularly those of Northern European origin. This haplotype has been associated with a number of variations in immunological function <ref type="bibr" target="#b102">103</ref> including an alteration in the cytokines produced, as well as differences in the early stages of cellular activation.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MAJOR HISTOCOMPATIBILITY COMPLEX AND SPORADIC INCLUSION-BODY MYOSITIS</head><p>The strong association of HLA-DR3 and the extended 8.1 AH with sIBM was first reported in 1994 by <ref type="bibr">Garlepp et al. 47</ref> This association between sIBM and alleles characteristic of 8.1 AH has subsequently been confirmed in a number of studies <ref type="bibr" target="#b21">22,</ref><ref type="bibr" target="#b70">71,</ref><ref type="bibr" target="#b77">78,</ref><ref type="bibr" target="#b103">104</ref> (Table 1). Identification of the critical MHC genes is hampered by very strong linkage disequilibrium in the 8.1 AH, which extends relatively stably over a distance of at least 3 Mb.</p><p>In considering the HLA data available, it became clear that within the MHC the association with sIBM was stronger with HLA-DR3 than with HLA-B8, so that the region of interest was considered to be closer to HLA-DR than to HLA-B (Garlepp et al., unpubl.). Further refinement by mapping of recombinant AH in patients with sIBM using the HSP70 and TNF markers narrowed the region to between HLA-DR and complement C4 <ref type="bibr" target="#b71">72</ref> (Fig. <ref type="figure" target="#fig_0">1</ref>). Subsequent work by the same group enabled the exclusion of genes centromeric of HLA-DR and DQ, at least in Caucasians. <ref type="bibr" target="#b102">103</ref> Fine mapping using microsatellites and SNPs has narrowed the susceptibility region to between PBX2 and HLA-DRB1. <ref type="bibr" target="#b103">104</ref> In considering the identification of an MHCencoded susceptibility gene for sIBM, it is important to consider the possible disease mechanisms. As indicated above, pathological features of the disease include accumulation of a range of proteins, particularly ␤-amyloid, vacuolar degeneration, and an inflammatory infiltrate, characterized by a predominance of CD8 ϩ T-cells, which are often intimately associated with muscle fiber membranes. CD8 ϩ Tcells interact with class I MHC antigens on target cells, and immunohistochemical staining of biopsies from patients with sIBM often reveals upregulation of MHC class I antigen expression on muscle cells. MHC class II overexpression on muscle cells is not a commonly reported feature of sIBM, so that a direct role for MHC class II as a target for T-cell damage is unlikely. However, an indirect role via antigen presentation by antigen-presenting cells cannot be excluded.</p><p>It is not clear whether the inflammation seen in sIBM is causative of the muscle degeneration or is a response to the degeneration and abnormal accumulation of the proteins characteristic of the disease. Indeed, some early data suggested that the degenerative process can continue despite control of the inflammatory response, a possible explanation for the reported lack of efficacy of corticosteroids in the treatment of sIBM. <ref type="bibr" target="#b23">24</ref> The association with the 8.1 AH may reflect the influence of this haplotype on the inflammatory response but, given the range of genes in the MHC that control nonimmunological functions and the detailed mapping that has focused interest in the 8.1 AH to a region telomeric of DRB1, it is appropriate to consider genes without an obvious immunological function that are located in this region.</p><p>A few genes within this region have been suggested as candidates for further study, including BTNL2 (butyrophilin-like MHC class II-associated gene, which is expressed in skeletal muscle), TSBP (testis-specific basic protein), NOTCH4 (a transmembrane receptor that regulates cell fate decisions), GPSM3 (a predicted gene with an unknown function previously known as G18), and AGER (advanced glycosylation end product-specific receptor, previously known as RAGE). <ref type="bibr" target="#b71">72,</ref><ref type="bibr" target="#b103">104</ref> AGER is located approximately 150 kb centromeric to the C4 gene (Fig. <ref type="figure" target="#fig_0">1</ref>) and is a member of the immunoglobulin superfamily of cell-surface molecules. It acts as a binding site for advanced glycation end products (which are formed as a consequence of irreversible glycation of protein or lipids) as well as the ␤-amyloid fragment of APP. Increased expression of AGER has been demonstrated in the brains of patients with Alzheimer's disease, and in vitro binding of ␤-amyloid to AGER expressed in neurons has been shown to be neurotoxic. <ref type="bibr" target="#b124">125</ref> AGER-mediated activation of NFB has also been observed in various cell types, particularly endothelial cells and mononuclear leukocytes. <ref type="bibr" target="#b56">57</ref> AGER protein is upregulated in regenerating muscle fibers and mononuclear cells in polymyositis and dermatomyositis <ref type="bibr" target="#b56">57</ref> but has not been reported in sIBM.</p><p>In addition to the 8.1 AH, other AH and alleles have been associated with sIBM. In the US, Love et al. <ref type="bibr" target="#b79">80</ref> reported an association of sIBM with HLA-DR52, which probably reflected the association with the 8.1 AH, although DR52 is also part of a number of other AHs. Price et al. <ref type="bibr" target="#b103">104</ref> found that the 35.2 AH (defined by DR1, BTNL2(E6)*2, PBX2*T, AGER*T, and B35) was increased in sIBM and suggested that this haplotype may also confer susceptibility to sIBM in Caucasians. In Japanese sIBM patients, Scott et al. <ref type="bibr" target="#b111">112</ref> reported an association with HLA-B*5201 and HLA-DRB1*1502, which are found together as part of the conserved 52.1 AH (defined as HLA-A*2402, Cw*1202, B*5201, DRB1*1502, DQA1*0103, DQB1*0601). In the Japanese population, the 52.1 AH is also associated with susceptibility to Takayasu's arteritis <ref type="bibr" target="#b68">69,</ref><ref type="bibr" target="#b69">70</ref> and ulcerative colitis. <ref type="bibr" target="#b117">118</ref> Association with the 52.1 AH was also found in an Ashkenazi Jewish patient with fIBM. <ref type="bibr" target="#b84">85</ref> The 8.1, 35.2, and 52.1 AHs do not share any common alleles, which suggests that the genes responsible for disease etiology are not HLA genes per se, but reside elsewhere in the MHC. <ref type="bibr" target="#b111">112</ref> Alternatively, of course, this observation may reflect differences in inducing agents or background genes at other loci that interact with different MHC AHs.</p><p>In addition, a study by O'Hanlon et al. <ref type="bibr" target="#b94">95</ref> of 571 North American Caucasian myositis patients, including 53 sIBM cases, confirmed the association of sIBM with multiple alleles including DRB1*0101, DQA1*0101, HLA-A*03, B*35, and Cw*04. They also reported that DQA1*0201 allele and the associated peptide-binding motif ( 47 KLPLFHRL <ref type="bibr" target="#b53">54</ref> ) and the DRB1*04-DQA1*03 haplotype were protective factors for sIBM. Badrising et al. <ref type="bibr" target="#b21">22</ref> in a study of 52 Dutch IBM patients also reported that HLA-DR53 may be protective. HLA-DR53 is the alternative allele to DR52 at the DRB3 locus and so the decrease in its frequency may reflect the increase in DR52 in sIBM. It is sometimes difficult to ascribe a protective role for HLA alleles in the presence of a very high frequency of particular alleles in disease.</p><p>Thus, to date, at least three AHs have been associated with sIBM, with the 8.1 AH being the predominant one in Caucasians. Identification of the actual genes involved will be important in helping to elucidate the pathogenesis of sIBM. Sporadic IBM is a complex disease, and although the MHC contains important genetic determinants, there are clearly other susceptibility genes and environmental factors that are likely to play a role in disease development.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>GENES ENCODING PROTEINS CHARACTERISTIC OF SPORADIC INCLUSION-BODY MYOSITIS</head><p>In general, the aggregation of proteins in any tissue may be a consequence of increased transcription, impaired breakdown, inappropriate protein assembly, aberrant modification, or environmental stress. <ref type="bibr" target="#b66">67</ref> Askanas and Engel <ref type="bibr" target="#b19">20</ref> proposed in a recent review that the formation of the characteristic ubiquitinated multiprotein inclusions in sIBM muscle is due primarily to protein unfolding and misfolding related to ␤-amyloid accumulation, rather than increased transcription of the various proteins. Unfolded or misfolded proteins are thought to aggregate due to the interaction of partly unfolded or misfolded polypeptides by virtue of inappropriately exposed hydrophobic surfaces. <ref type="bibr" target="#b38">39</ref> Correctly folded proteins are soluble or remain localized to intracellular structures or associated with cell membranes. Amino acid sequence variation as a consequence of gene mutation has the potential to trigger such events; therefore, candidate susceptibility genes for sIBM include those encoding the deposited proteins.</p><p>More than 20 proteins that have a propensity to unfold, misfold, and form ␤-pleated sheet amyloid have been found to accumulate in muscle fibers in sIBM. Thus far, a number of genes related to the various "Alzheimer-type" proteins as well as some that have been identified as potential susceptibility genes for Alzheimer's disease have been studied as candidate genes for sIBM. Although these studies have not yet revealed any definite susceptibility genes, the existing data are summarized here.</p><p>The expression of a number of nonimmune genes is reportedly increased in sIBM muscle based on differential expression at the protein level, mRNA level, or both. These include ␤-amyloid precursor protein, <ref type="bibr" target="#b108">109</ref> phosphorylated tau, <ref type="bibr" target="#b10">11</ref> ubiquitins, <ref type="bibr" target="#b6">7</ref> prion protein, 110 alpha 1 antichymotrypsin (␣1ACT), <ref type="bibr" target="#b25">26</ref> ApoE, <ref type="bibr" target="#b86">87</ref> copper zinc superoxide dismutase (SOD1), <ref type="bibr" target="#b12">13</ref> and manganese superoxide dismutase (SOD2), <ref type="bibr" target="#b119">120</ref> apoptotic regulators Bcl-2, Bcl-x, and BAX, <ref type="bibr" target="#b101">102</ref> and lipoprotein receptors. <ref type="bibr" target="#b62">63</ref> Microarray studies, such as that done by Greenberg et al., <ref type="bibr" target="#b51">52</ref> confirmed the increased expression, at the mRNA level, of ␤-amyloid, ApoE, SOD2, BAX, low-density lipoprotein receptors, and low-density lipoprotein receptor-related protein, but also found all of these genes overexpressed in other inflammatory myopathies, some at much higher-fold ratios than in sIBM. Furthermore, they found tau expression to be increased 6.8-fold in dermatomyositis and ␣1ACT 6.8fold in polymyositis compared to healthy muscle. Furthermore, a recent study <ref type="bibr" target="#b106">107</ref> showed that the genes encoding most of the proteins that aberrantly accumulate in the muscle fibers in desmin myopathy are not upregulated or altered compared to hIBM. To the contrary, genes encoding ␣-actin and gelsolin are more upregulated in hIBM than desmin myopathy muscle. These findings are consistent with the hypothesis that many of the nonimmune changes at the level of mRNA expression seen in IBM are nonspecific and may also be seen in other myopathies, suggesting that abnormal accumulation of these proteins is due to posttranscriptional events. Microarray technology measuring levels of mRNA allows identification of genes that are upregulated and downregulated, but provides no information regarding cause or effect. In addition, it is limited by available knowledge of gene function and sequence and the accuracy of gene databases. However, these tech-niques can be useful in identifying further candidate genes for study.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>␤-AMYLOID</head><p>It has been established that ␤-amyloid, the C and N-terminal regions of APP, and APP mRNA accumulate in both sIBM and hIBM, 8 with the ␤-amyloid42 isoform being more common than ␤-amyloid40. <ref type="bibr" target="#b19">20</ref> ␤-Amyloid42 is more hydrophobic, more prone to self association and oligomer formation to generate beta-pleated sheet amyloid, and more cytotoxic than ␤-amyloid40, <ref type="bibr" target="#b28">29</ref> and has been correlated with apoptotic cell death. <ref type="bibr" target="#b104">105</ref> The accumulation of APP and its fragments is often stated to precede other abnormalities in IBM muscle fibers, including congophilia, <ref type="bibr" target="#b15">16</ref> suggesting that it plays an important early role in disease. Moreover, both cell culture <ref type="bibr" target="#b13">14</ref> and transgenic mouse models overexpressing APP <ref type="bibr" target="#b45">46,</ref><ref type="bibr" target="#b63">64</ref> display some of the key features of IBM. The mechanism of overproduction is not yet fully elucidated, but some of the genes responsible for early-onset Alzheimer's disease have been investigated.</p><p>Mutations in exons 16 and 17 of the APP gene on chromosome 21 have been identified in patients with early-onset familial Alzheimer's disease. Similar studies in sIBM and hIBM did not find mutations in these exons <ref type="bibr" target="#b114">115</ref>  (Garlepp et al., unpublished data), although this does not completely exclude the possibility that a mutation could be present elsewhere in the gene. It is of interest, however, that individuals with trisomy 21 who have an extra copy of the APP gene and universally develop Alzheimer's disease by the age of 40 years, and sometimes as young as 20 years, <ref type="bibr" target="#b121">122</ref> are not reported to have a higher incidence of sIBM.</p><p>Mutations in the presenilin 1 (PS1) and presenilin 2 (PS2) genes are also responsible for familial early-onset Alzheimer's disease. Mutations in these genes lead to selective increase in the levels of ␤-amy-loid42 species. <ref type="bibr" target="#b121">122</ref> Although PS1 accumulates in the brain in both sporadic and familial Alzheimer's disease, missense mutations are not found in the sporadic form of the disease. In sIBM, although PS1 protein has been demonstrated immunohistochemically in muscle fibers in both hIBM and sIBM, <ref type="bibr" target="#b14">15</ref> mutations in the PS1 or PS2 genes have not yet been investigated in either hIBM or sIBM.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>APOLIPOPROTEIN E</head><p>ApoE protein but not mRNA has been found in both hIBM and sIBM inclusions. <ref type="bibr" target="#b86">87</ref> The apoE ⑀4 allele is known to be a risk factor for developing late-onset sporadic Alzheimer's disease. Although one study found an increased frequency of the ⑀4 allele in sIBM, <ref type="bibr" target="#b47">48</ref> four other studies have not replicated this finding. <ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b49">50,</ref><ref type="bibr" target="#b55">56,</ref><ref type="bibr" target="#b80">81</ref> The differences between these studies may reflect genetic heterogeneity in this disease, and the fact that genetic predisposition to the development of IBM is probably multifactorial. If ApoE ⑀4 is a predisposing factor to the development or progression of sIBM, then it is clearly not the dominant factor and may have its effect via interaction with other genetic and environmental influences. The elucidation of whether ApoE alleles actually influence the development of sIBM is difficult, largely because of difficulties in obtaining a control group who have all the risk factors for developing sIBM but do not manifest the disease. <ref type="bibr" target="#b24">25</ref> However, it remains that significant numbers of patients are negative for the ApoE ⑀4 allele, emphasizing the likelihood that other factors contribute more strongly to disease pathogenesis.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>␣-1-ANTICHYMOTRYPSIN</head><p>␣1ACT is considered an acute-phase protein that belongs to the serpin superfamily and inhibits serine proteases. Like ApoE, it binds to ␤-amyloid peptide with high affinity and is a strong stimulatory factor in the polymerization of ␤-amyloid peptide into filaments. Abnormal ␣1ACT accumulations are found in sIBM muscle and it colocalizes with ␤-amyloid, <ref type="bibr" target="#b25">26</ref> as is the case in the brains of patients with Alzheimer's disease. In Alzheimer's disease a common polymorphism of the ␣1ACT gene (A/A) has been shown to modify the risk of developing disease conferred by ApoE ⑀4. The combination of ␣1ACT (A/A) and ApoE ⑀4 was found to occur more frequently in Alzheimer's disease than in the general population, <ref type="bibr" target="#b64">65</ref> and increased the risk of developing disease 2-3-fold beyond the risk associated with possession of ApoE ⑀4 alone. <ref type="bibr" target="#b59">60,</ref><ref type="bibr" target="#b64">65</ref> Nacmias et al. <ref type="bibr" target="#b89">90</ref> found that this association was most important in the subset of late-onset familial Alzheimer's disease, but the ␣1ACT genotype did not represent an additional risk factor in families that carried mutations in the APP, PS-1 or PS-2 genes. The ␣1ACT polymorphisms by themselves do not seem to be an independent risk factor for Alzheimer's disease. Gossrau et al. <ref type="bibr" target="#b49">50</ref> analyzed ApoE and ␣1ACT gene polymorphisms in 35 sIBM patients and could not identify any statistically significant correlation between the distinct ApoE and ␣1ACT genotypes and the risk of developing sIBM. However, the numbers in this study were small, with only seven patients having the ␣1ACT (A/A) polymorphism, no patients being homozygous for Apo⑀4/⑀4, and only 8 of 35 patients being Apo⑀3/⑀4 heterozygous, so that definite conclusions are not possible, and larger studies need to be performed.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>PRION PROTEIN</head><p>Prion protein and prion mRNA are also accumulated in sIBM and hIBM <ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b109">110</ref> (as well as other inflammatory myopathies), although only the normal isoform PrP c , not PrP sc (the protease-resistant insoluble isoform) has been detected. <ref type="bibr" target="#b125">126</ref> A study by Orth et al. <ref type="bibr" target="#b97">98</ref> analyzing 41 sIBM patients for codon 129 amino acid status found that 21 patients were homozygous for methionine (Met), one patient was homozygous for valine, and 19 were heterozygous. This was not significantly different from the normal population, suggesting that sIBM is not linked to the Met/Met polymorphism at codon 129 of the prion protein gene. These data are consistent with data from our own group (Garlepp et al., unpublished data), but contrasts with the original report by Lampe et al., <ref type="bibr" target="#b75">76</ref> who reported that 64% of their 22 sIBM patients were homozygous for Met/Met polymorphism at codon 129. They subsequently revised this <ref type="bibr" target="#b76">77</ref> after studying a further 16 patients, when they reported a reduced frequency of 55%.</p><p>Although examination of the genes encoding the proteins accumulated in sIBM has not yet identified any of them as susceptibility genes, their accumulation remains an important, undisputed feature of the disease. The genetic analysis to date has been somewhat targeted, and in most cases analysis of the complete gene has not been conducted, cues having been taken from data accumulated for Alzheimer's disease. The control of expression of these proteins and their metabolism is often complex, so that complete exclusion of genetic variation in these processes in sIBM will require more intensive analysis. Understanding why these proteins accumulate and how they contribute to the etiology, pathogenesis, and progression of sIBM remains a key issue in sIBM.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MITOCHONDRIAL DNA (mtDNA) ABNORMALITIES</head><p>Another important feature of sIBM pathology, and one that may lead to the identification of further susceptibility genes, is the mitochondrial changes seen in cytochrome-oxidase (COX)-deficient muscle fibers and ragged-red fibers (RRF). These are more prevalent in sIBM compared with normal aging, polymyositis, or dermatomyositis. A recent review by Oldfors et al. <ref type="bibr" target="#b96">97</ref> summarized the mitochondrial changes seen in sIBM, and highlighted new tech-niques that have enabled many discoveries in the last decade.</p><p>The application of in-situ hybridization allowed the demonstration that many COX-deficient RRF had accumulated large-scale deletions in mtDNA. Extended studies, using different DNA probes on serial sections, found different deletions in separate muscle-fiber segments, implying that clones of mtDNA with large-scale deletions had expanded focally causing segmental COX-deficiency. <ref type="bibr" target="#b96">97</ref> A study by Horvath et al. <ref type="bibr" target="#b61">62</ref> found by detailed in-situ hybridization a patient with a large number of affected fibers that large-scale single mtDNA deletions were the most common mtDNA abnormalities observed in COX-deficient fibers. Oldfors et al., <ref type="bibr" target="#b95">96</ref> using sensitive polymerase chain reaction (PCR) analysis, demonstrated that multiple mtDNA deletions were found in most sIBM patients, whereas PCR analysis of isolated, single muscle fibers showed the presence of mtDNA with only one type of deletion, and the deficiency of wildtype mtDNA in each COX-deficient muscle fiber. This finding was supported by results from insitu hybridization using different mtDNA probes on consecutive sections. The etiology of multiple mtDNA deletions and COX-deficient fibers in sIBM is not clear, and they may be a nonspecific finding, as clonal expansion of somatic multiple large-scale mtDNA deletions has been demonstrated in other conditions including late-onset mitochondrial myopathy, autosomal-dominant chronic progressive external ophthalmoplegia, and to a lesser degree in normal aging. Oldfors et al. <ref type="bibr" target="#b96">97</ref> investigated the POLG1, ANT1 and C10orf2 mitochondrially encoded genes, as variants of these genes have previously been associated with multiple mtDNA mutations, and did not find any mutations in these genes in five sIBM patients.</p><p>MtDNA variants have been shown to be associated with many diseases. Mutations at mtDNA nucleotide positions 3192, 3196, 3397, and 4336 have been described in association with late-onset Alzheimer's disease. These were analyzed in sIBM patients by Kok et al., <ref type="bibr" target="#b72">73</ref> and in this study the 4336G variant was not significantly increased in patients with either sIBM or Alzheimer's disease compared with controls. None of the patients with sIBM carried mutations at nucleotide positions 3192, 3196, or 3397. Phylogenetic analysis of patients with sIBM, Alzheimer's disease, and controls based on D loop sequence showed that individuals with 4336G and 4580A variants clustered together in their respective group, as would be predicted. A group of patients with IBM also clustered together on a separate branch of the phylogenetic tree, independent of these polymorphisms.</p><p>Closer investigation of this group revealed a common polymorphism at nucleotide position 16311. The frequency of the 16311C variant was higher in sIBM than in Alzheimer's disease and controls, although when only Caucasian patients were considered the increased frequency was not statistically significant. Further studies will be required to determine whether this variant plays a role in the pathogenesis of sIBM. <ref type="bibr" target="#b72">73</ref> The significance of the mtDNA deletions in sIBM is unclear, particularly given that magnetic resonance spectroscopy (MRS) studies using 31P MRS has not shown any impairment of oxidative metabolism in sIBM patients. <ref type="bibr" target="#b4">5,</ref><ref type="bibr" target="#b78">79</ref> However, in normal aging mtDNA mutations have been associated with muscle fiber atrophy, and they may be an important factor in the sarcopenia associated with aging. By the same token, mtDNA mutations in sIBM muscle may contribute to the muscle atrophy and weakness. It has been proposed that the mitochondrial abnormalities are a consequence of muscle damage or other factors involved in the disease process such as the APP gene (as cultured muscle cells overexpressing APP also show evidence of mitochondrial abnormalities) or the proinflammatory cytokine IL-1␤ (as myotubes treated with IL-1 have abnormal mitochondria <ref type="bibr" target="#b29">30</ref> ). The overwhelming opinion appears to be that these mitochondrial changes are a secondary phenomenon to the cellular abnormalities occurring in sIBM, rather than being a primary pathogenic abnormality.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>CONCLUSIONS</head><p>The pathogenesis of sIBM is slowly being elucidated, and is likely to involve a complex interaction between environmental triggers (possibly viral) and genetic susceptibility. In-depth histopathological studies have identified three important features: the immune changes, degenerative changes of protein accumulation, and mitochondrial changes. Research into candidate genes in all of these areas over the last decade has shown that genes located within the MHC are most strongly associated with sIBM. Genes encoded within mtDNA, genes associated with reactive oxygen species production and breakdown, as well as genes controlling proteasomal protein breakdown and the immune system are areas warranting future studies. The identification of the genetic factors that influence the development and progression of this currently difficult to control disease will not only be a tremendous step forward in understanding the process of the disease but should allow the development of targeted therapies.</p><p>Supported by NHMRC (grant number 392500) and the Neuromuscular Foundation of Western Australia.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>FIGURE 1 .</head><label>1</label><figDesc>FIGURE 1. Schematic representation of the MHC showing susceptibility region in sIBM.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc>Frequency of DR3 (DRB1*0301) and HLA-B8 alleles in sIBM.</figDesc><table><row><cell></cell><cell>Frequency of DR3 in sIBM</cell><cell>Frequency of HLA-B8 in sIBM</cell><cell></cell></row><row><cell>Reference no.</cell><cell>(control population)</cell><cell>(Control population)</cell><cell>Country of study</cell></row><row><cell>80</cell><cell>52% (not stated)</cell><cell>Not reported</cell><cell>USA</cell></row><row><cell>47</cell><cell>93% (15%)</cell><cell>75% (28%)</cell><cell>Australia</cell></row><row><cell>71</cell><cell>77% (15%)</cell><cell>Not reported</cell><cell>USA</cell></row><row><cell>78</cell><cell>27% (10%)</cell><cell>21% (9%)</cell><cell>Germany</cell></row><row><cell>22</cell><cell>79% (25%)</cell><cell>69% (23%)</cell><cell>Netherlands</cell></row><row><cell>104</cell><cell>74% (28%)</cell><cell>67% (29%)</cell><cell>Australia</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="10974598" xml:id="foot_0">, 2007, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/mus.20766 by University Of Illinois At Urbana Champaign, Wiley Online Library on [31/01/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_1">MUSCLE &amp; NERVE May 2007 10974598, 2007, 5, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/mus.20766 by University Of Illinois At Urbana Champaign, Wiley Online Library on [31/01/2023]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License</note>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Inclusion body myositis: clinical and pathological boundaries</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Amato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Gronseth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Jackson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Wolfe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Katz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">W</forename><surname>Bryan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="581" to="586" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Inclusion body myositis in twins</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Amato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Shebert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="598" to="600" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Rimmed vacuole myopathy&quot; sparing the quadriceps: a unique disorder in Iranian Jews</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Argov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Yarom</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurol Sci</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="33" to="43" />
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Various types of hereditary inclusion body myopathies map to chromosome 9p1-q1</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Argov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Tiram</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Eisenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sadeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Seidman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Seidman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="548" to="551" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Intracellular phosphates in inclusion body myositis-a 31P magnetic resonance spectroscopy study</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Argov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Taivassalo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Stefano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Genge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Karpati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Arnold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Muscle Nerve</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="1523" to="1525" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Hereditary inclusion body myopathy: the Middle Eastern genetic cluster</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Argov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Eisenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Grabov-Nardini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sadeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Wirguin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Soffer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="1519" to="1523" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Immunocytochemical localization of ubiquitin in inclusion body myositis allows its light-microscopic distinction from polymyositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Serdaroglu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="460" to="461" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Beta-Amyloid precursor epitopes in muscle fibers of inclusion body myositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="551" to="560" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Prion protein is abnormally accumulated in inclusionbody myositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bilak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Tome</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Leclerc</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroreport</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="25" to="28" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">New advances in inclusion-body myositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Rheumatol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="732" to="741" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Twisted tubulofilaments of inclusion body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bilak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Selkoe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="page" from="177" to="187" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Apolipoprotein E alleles in sporadic inclusion-body myositis and hereditary inclusion-body myopathy</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mirabella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Weisgraber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Saunders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Roses</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="264" to="265" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">SOD1 gene and protein in vacuolated muscle fibers of s-IBM, h-IBM, and in cultured human muscle after bAPP gene transfer</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sarkozi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcferrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Siddique</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page">487</biblScope>
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Beta APP gene transfer into cultured human muscle induces inclusion-body myositis aspects</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcferrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Baque</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroreport</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="2155" to="2158" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Light and electron microscopic immunolocalization of presenilin 1 in abnormal muscle fibers of patients with sporadic inclusion-body myositis and autosomal-recessive inclusion-body myopathy</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wisniewski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">152</biblScope>
			<biblScope unit="page" from="889" to="895" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Novel immunolocalization of alpha-synuclein in human muscle of inclusion-body myositis, regenerating and necrotic muscle fibers, and at neuromuscular junctions</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mcferrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Broccolini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neuropathol Exp Neurol</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="592" to="598" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Inclusion-body myositis: newest concepts of pathogenesis and relation to aging and Alzheimer disease</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neuropathol Exp Neurol</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="1" to="14" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Unfolding story of inclusion-body myositis and myopathies: role of misfolded proteins, amyloid-beta, cholesterol, and aging</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Child Neurol</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="185" to="190" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Molecular pathology and pathogenesis of inclusion-body myositis</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Microsc Res Tech</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="114" to="120" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition</title>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="S39" to="48" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Epidemiology of inclusion body myositis in the Netherlands: a nationwide study</title>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">A</forename><surname>Badrising</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Maat-Schieman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Van Duinen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Breedveld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Van Doorn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Van Engelen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="1385" to="1387" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis</title>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">A</forename><surname>Badrising</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Gmt</forename><surname>Schreuder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Giphart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Geleijns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jjgm</forename><surname>Verschuuren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Wintzen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="2396" to="2398" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Inclusion body myositis. Clinical features and clinical course of the disease in 64 patients</title>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">A</forename><surname>Badrising</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mlc</forename><surname>Maat-Schieman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Van Houwelingen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Van Doorn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Van Duinen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Bgm</forename><surname>Van Engelen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurol</title>
		<imprint>
			<biblScope unit="volume">252</biblScope>
			<biblScope unit="page" from="1448" to="1454" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Inclusion body myositis: explanation for poor response to immunosuppressive therapy</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Barohn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Amato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Sahenk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Kissel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Mendell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="1302" to="1304" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Apolipoprotein E and neuromuscular disease: a critical review of the literature</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Bedlack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Strittmatter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Morgenlander</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Neurol</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="1561" to="1565" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Strong immunoreactivity of alpha 1-antichymotrypsin co-localizes with beta-amyloid protein and ubiquitin in vacuolated muscle fibers of inclusionbody myositis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Bilak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Neuropathol (Berl)</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="378" to="382" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">alpha-Dystroglycan does not play a major pathogenic role in autosomal recessive hereditary inclusionbody myopathy</title>
		<author>
			<persName><forename type="first">A</forename><surname>Broccolini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gliubizzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Pavoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Gidaro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Morosetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Sciandra</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuromuscul Disord</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="177" to="184" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Familial myopathy with changes resembling inclusion body myositis and periventricular leucoencephalopathy. A new syndrome</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Cole</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kuzniecky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Karpati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Carpenter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Andermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Andermann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="page" from="1025" to="1037" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">N</forename><surname>Dahlgren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Manelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Wbj</forename><surname>Stine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Baker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Krafft</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Ladu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">277</biblScope>
			<biblScope unit="page" from="32046" to="32053" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Molecular immunology and genetics of inflammatory muscle diseases</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Neurol</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="1509" to="1512" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Sporadic inclusion body myositis -diagnosis, pathogenesis and therapeutic strategies</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Clin Pract</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="437" to="445" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Autosomal dominant myopathy with congenital joint contractures, ophthalmoplegia, and rimmed vacuoles</title>
		<author>
			<persName><forename type="first">N</forename><surname>Darin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kyllerman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wahlstrom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Martinsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Oldfors</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="242" to="248" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Magnesium may help patients with recessive hereditary inclusion body myopathy, a pathological review</title>
		<author>
			<persName><forename type="first">D</forename><surname>Darvish</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Med Hypotheses</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="94" to="101" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Ancestral haplotypes: conserved population MHC haplotypes</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Degli-Esposti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Leaver</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">T</forename><surname>Christiansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Witt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Abraham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Dawkins</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Immunol</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="242" to="252" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Partial laminin ␣2 chain deficiency in a patient with myopathy resembling inclusion body myositis</title>
		<author>
			<persName><forename type="first">Di</forename><surname>Blasi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mora</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pareyson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Farina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Sghirlanzoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vignier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="811" to="816" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Fine-structure mapping of the hereditary inclusion body myopathy locus</title>
		<author>
			<persName><forename type="first">I</forename><surname>Eisenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Thiel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Levi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Tiram</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Argov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sadeh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genomics</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="43" to="48" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy</title>
		<author>
			<persName><forename type="first">I</forename><surname>Eisenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Avidan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Potikha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hochner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Olender</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="83" to="87" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Mutations spectrum of GNE in hereditary inclusion body myopathy sparing the quadriceps</title>
		<author>
			<persName><forename type="first">I</forename><surname>Eisenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Grabov-Nardini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hochner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Korner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sadeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Bertorini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Mutat</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page">99</biblScope>
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Danger: misfolding proteins</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Ellis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Tjt</forename><surname>Pinheiro</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">416</biblScope>
			<biblScope unit="page" from="483" to="484" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Inclusion body myositis in Connecticut: observations in 35 patients during an 8-year period</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Felice</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>North</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Medicine (Balt)</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="page" from="320" to="327" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Proteasomal expression, induction of immunoproteasome subunits, and local MHC class I presentation in myofibrillar myopathy and inclusion body myositis</title>
		<author>
			<persName><forename type="first">I</forename><surname>Ferrer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Castano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Lucas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Moreno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Olive</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neuropathol Exp Neurol</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="484" to="498" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Involvement of clusterin and the aggresome in abnormal protein deposits in myofibrillar myopathies and inclusion body myositis</title>
		<author>
			<persName><forename type="first">I</forename><surname>Ferrer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Carmona</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Blanco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Moreno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Torrejon-Escribano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Olive</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain Pathol</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="101" to="108" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Familial inclusion body myopathy with desmin storage</title>
		<author>
			<persName><forename type="first">A</forename><surname>Fidzianska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Drac</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Kaminska</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Neuropathol (Berl)</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="509" to="514" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Coexistence of X-linked recessive Emery-Dreifuss muscular dystrophy with inclusion body myositis-like morphology</title>
		<author>
			<persName><forename type="first">A</forename><surname>Fidzianska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Rowinska-Marcinska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Hausmanowa-Petrusewicz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Neuropathol (Berl)</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="page" from="197" to="203" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Inclusion body myositis and neuromuscular diseases with rimmed vacuoles</title>
		<author>
			<persName><forename type="first">D</forename><surname>Figarella-Branger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Pellissier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Pouget</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">E</forename><surname>Calore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Azulay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Desnuelle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Rev Neurol</title>
		<imprint>
			<biblScope unit="volume">148</biblScope>
			<biblScope unit="page" from="281" to="290" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Amyloid-beta deposition in skeletal muscle of transgenic mice: possible model of inclusion body myopathy</title>
		<author>
			<persName><forename type="first">K</forename><surname>Fukuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Pham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Lindsey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">153</biblScope>
			<biblScope unit="page" from="1687" to="1693" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">HLA associations with inclusion body myositis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Garlepp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Laing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Zilko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Ollier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mastaglia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Immunol</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page" from="40" to="45" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Apolipoprotein E epsilon 4 in inclusion body myositis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Garlepp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Tabarias</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Van Bockxmeer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Zilko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Laing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Mastaglia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="957" to="959" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells</title>
		<author>
			<persName><forename type="first">D</forename><surname>Goldgaber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">W</forename><surname>Harris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hla</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="page" from="7606" to="7610" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Apolipoprotein E and alpha-1-antichymotrypsin polymorphisms in sporadic inclusion body myositis</title>
		<author>
			<persName><forename type="first">G</forename><surname>Gossrau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Gestrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Koch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wunderlich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Schroder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schroeder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Neurol</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="215" to="220" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Single nucleotide polymorphisms in the dystroglycan gene do not correlate with disease severity in hereditary inclusion body myopathy</title>
		<author>
			<persName><forename type="first">E</forename><surname>Gottlieb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ciccone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Darvish</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Naiem-Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Savelkoul</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Genet Metab</title>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="page" from="244" to="249" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Molecular profiles of inflammatory myopathies</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Greenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Sandoudou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Haslett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">S</forename><surname>Kohane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Kunkel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Beggs</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="1170" to="1182" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Inclusion body myositis and myopathies</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Griggs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dimauro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Karpati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Mendell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="705" to="713" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Identification and characterization of a B/Rel binding site in the regulatory region of the amyloid precursor protein gene</title>
		<author>
			<persName><forename type="first">M</forename><surname>Grilli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ribola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Alberici</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Valerio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Memo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Spano</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">270</biblScope>
			<biblScope unit="page" from="26774" to="26777" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Interleukin-1beta and glutamate activate the NF-kappa B/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures</title>
		<author>
			<persName><forename type="first">M</forename><surname>Grilli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Goffi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Memo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Spano</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">271</biblScope>
			<biblScope unit="page" from="15002" to="15007" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Apolipoprotein E type epsilon 4 allele frequency is not increased in patients with sporadic inclusion-body myositis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Harrington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Chan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosci Lett</title>
		<imprint>
			<biblScope unit="volume">183</biblScope>
			<biblScope unit="page" from="35" to="38" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Haslbeck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Friess</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Schleicher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bierhaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Nawroth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kirchner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Neuropathol</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="page" from="247" to="254" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Inclusion body myopathy and Paget disease is linked to a novel mutation in the VCP gene</title>
		<author>
			<persName><forename type="first">D</forename><surname>Haubenberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Bittner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rauch-Shorny</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Zimprich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mannhalter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wagner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="1304" to="1305" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Familial inclusion body myositis with histologically confirmed sensorimotor axonal neuropathy</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Hengstman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">G</forename><surname>Van Engelen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Ter Laak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Gabreels-Festen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurol</title>
		<imprint>
			<biblScope unit="volume">247</biblScope>
			<biblScope unit="page" from="882" to="884" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">ACT/AA polymorphism could duplicate the APOE*epsilon4-associated Alzheimer&apos;s disease risk</title>
		<author>
			<persName><forename type="first">B</forename><surname>Hernandez-Charro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Moreno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Valiente</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Manubens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Villar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Ramos-Arroyo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Med Clin (Barc)</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="page" from="251" to="254" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Gene map of the extended human MHC</title>
		<author>
			<persName><forename type="first">R</forename><surname>Horton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wilming</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Rand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Lovering</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Bruford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">K</forename><surname>Khodiyar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Genet</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="889" to="899" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Characterisation of the mitochondrial DNA abnormalities in the skeletal muscle of patients with inclusion body myositis</title>
		<author>
			<persName><forename type="first">R</forename><surname>Horvath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Fu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Johns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Genge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Karpati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Shoubridge</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neuropathol Exp Neurol</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="396" to="403" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Three lipoprotein receptors and cholesterol in inclusion-body myositis muscle</title>
		<author>
			<persName><forename type="first">M</forename><surname>Jaworska-Wilczynska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Wilczynski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">K</forename><surname>Strickland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Weisgraber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="438" to="445" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Transgenic mice over-expressing the C-99 fragment of betaPP with an alpha-secretase site mutation develop a myopathy similar to human inclusion body myositis</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">W</forename><surname>Jin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Hearn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Ogburn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Dang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Nochlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Ladiges</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">153</biblScope>
			<biblScope unit="page" from="1679" to="1686" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">APOE*4-associated Alzheimer&apos;s disease risk is modified by alpha1-antichymotrypsin polymorphism</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">I</forename><surname>Kamboh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">K</forename><surname>Sanghera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Ferrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Dekosky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="486" to="488" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Expression of immunoreactive major histocompatibility complex products in human skeletal muscles</title>
		<author>
			<persName><forename type="first">G</forename><surname>Karpati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Pouliot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Carpenter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="64" to="72" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">The Deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Kawaguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Kovacs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mclaurin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Vance</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>Yao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="page" from="727" to="738" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">Nonaka myopathy is caused by mutations in the UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase gene (GNE)</title>
		<author>
			<persName><forename type="first">T</forename><surname>Kayashima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Matsuo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Satoh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ohta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yoshiura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Matsumoto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Hum Genet</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="77" to="79" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">Comprehensive analysis of HLA genes in Takayasu arteritis in Japan</title>
		<author>
			<persName><forename type="first">A</forename><surname>Kimura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kitamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Date</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Numano</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Cardiol</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="S61" to="69" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Association of clinical manifestations with HLA-B alleles in Takayasu arteritis</title>
		<author>
			<persName><forename type="first">H</forename><surname>Kitamura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kobayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kimura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Numano</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Cardiol</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="S121" to="126" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">HLA allele distribution distinguishes sporadic inclusion body myositis from hereditary inclusion body myopathies</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">M</forename><surname>Koffman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sivakumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Simonis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Stroncek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neuroimmunol</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="139" to="142" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Mapping of a candidate region for susceptibility to inclusion body myositis in the human major histocompatibility complex</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Kok</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Croager</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Witt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Kiers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Mastaglia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Abraham</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunogenetics</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="508" to="516" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Mitochondrial DNA variants in inclusion body myositis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Kok</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Boyt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gaudieri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Martins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuromuscul Disord</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="604" to="611" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Kovach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Waggoner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Leal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Gelber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Khardori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Levenstien</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Genet Metab</title>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="page" from="458" to="475" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main">A novel homozygous missense mutation in the GNE gene of a patient with quadriceps-sparing hereditary inclusion body myopathy associated with muscle inflammation</title>
		<author>
			<persName><forename type="first">S</forename><surname>Krause</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Schlotter-Weigel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Walter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Najmabadi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wiendl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Muller-Hocker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuromuscul Disord</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="830" to="834" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">Methionine homozygosity at prion gene codon 129 may predispose to sporadic inclusion-body myositis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Lampe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kitzler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Walter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Lochmuller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Reichmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">353</biblScope>
			<biblScope unit="page" from="465" to="466" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">Prion codon 129 homozygosity and sporadic inclusion body myositis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Lampe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gossrau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Reichmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Walter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Mendel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Lochmuller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page">368</biblScope>
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">Analysis of HLA class I and II alleles in sporadic inclusion-body myositis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Lampe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gossrau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kempe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fussel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Schwurack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Schroder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurol</title>
		<imprint>
			<biblScope unit="volume">250</biblScope>
			<biblScope unit="page" from="1313" to="1317" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main">Normal in vivo skeletal muscle oxidative metabolism in sporadic inclusion body myositis assessed by 31 P-magnetic resonance spectroscopy</title>
		<author>
			<persName><forename type="first">R</forename><surname>Lodi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Tabrizi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hilton-Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Squier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Seller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="2119" to="2126" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main">A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Love</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Leff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Fraser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">N</forename><surname>Targoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dalakas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Plotz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Medicine (Balt)</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page" from="360" to="374" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main">Apolipoprotein E allele frequencies in sporadic inclusion body myositis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Love</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Nicoll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lowe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Sherriff</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Muscle Nerve</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="1605" to="1607" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main">Altered CYP21 genes in HLA-haplotypes associated with congenital adrenal hyperplasia (CAH): a family study</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Manfras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Swinyard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Rudert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Ball</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kuhnl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Genet</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="page" from="33" to="39" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b82">
	<analytic>
		<title level="a" type="main">Dominant hereditary inclusion-body myopathy gene (IBM3) maps to chromosome region 17p13.1</title>
		<author>
			<persName><forename type="first">T</forename><surname>Martinsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Darin</forename><forename type="middle">N</forename><surname>Kyllerman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Oldfors</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hallberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Wahlstrom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Hum Genet</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="1420" to="1426" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b83">
	<analytic>
		<title level="a" type="main">Autosomal dominant myopathy: missense mutation (Glu-706 3 Lys) in the myosin heavy chain IIa gene</title>
		<author>
			<persName><forename type="first">T</forename><surname>Martinsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Oldfors</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Darin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Berg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Tajsharghi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kyllerman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="14614" to="14619" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b84">
	<analytic>
		<title level="a" type="main">Familial inclusion body myositis in a mother and son with different ancestral MHC haplotypes</title>
		<author>
			<persName><forename type="first">F</forename><surname>Mastaglia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Walters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Fabian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Zilko</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuromuscul Disord</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="754" to="758" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b85">
	<analytic>
		<title level="a" type="main">Constitutive and cytokine-induced expression of human leukocyte antigens and cell adhesion molecules by human myotubes</title>
		<author>
			<persName><forename type="first">D</forename><surname>Michaelis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Goebels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hohlfeld</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">143</biblScope>
			<biblScope unit="page" from="1142" to="1149" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b86">
	<analytic>
		<title level="a" type="main">Apolipoprotein E and apolipoprotein E messenger RNA in muscle of inclusion body myositis and myopathies</title>
		<author>
			<persName><forename type="first">M</forename><surname>Mirabella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Weisgraber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="864" to="872" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b87">
	<analytic>
		<title level="a" type="main">Hereditary inclusion body myopathy maps to chromosome 9p1-q1</title>
		<author>
			<persName><forename type="first">S</forename><surname>Mitrani-Rosenbaum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Argov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Blumenfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Seidman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Seidman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Mol Genet</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="159" to="163" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b88">
	<analytic>
		<title level="a" type="main">Inclusion body myositis: clonal expansions of muscle-infiltrating Tcells persist over time</title>
		<author>
			<persName><forename type="first">K</forename><surname>Muntzing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lindberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Moslemi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Oldfors</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scand J Immunol</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="195" to="200" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b89">
	<analytic>
		<title level="a" type="main">Implication of ␣1-antichymotrypsin polymorphism in familial Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">B</forename><surname>Nacmias</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Marcon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tedde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Forleo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Latorraca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Piacentini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosci Lett</title>
		<imprint>
			<biblScope unit="volume">244</biblScope>
			<biblScope unit="page" from="85" to="88" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b90">
	<analytic>
		<title level="a" type="main">Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies</title>
		<author>
			<persName><forename type="first">K</forename><surname>Nagaraju</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Raben</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Loeffler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Parker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Rochon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="9209" to="9214" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b91">
	<analytic>
		<title level="a" type="main">Activation of the endoplasmic reticulum stress response in autoimmune myositis</title>
		<author>
			<persName><forename type="first">K</forename><surname>Nagaraju</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Casciola-Rosen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Lundberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Rawat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cutting</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Thapliyal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="1824" to="1835" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b92">
	<analytic>
		<title level="a" type="main">Familial inclusion body myositis: evidence for autosomal dominant inheritance</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E</forename><surname>Neville</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Baumbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Ringel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Russo</surname></persName>
		</author>
		<author>
			<persName><surname>Jr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sujansky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Garcia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="897" to="902" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b93">
	<analytic>
		<title level="a" type="main">Molecular pathomechanism of distal myopathy with rimmed vacuoles</title>
		<author>
			<persName><forename type="first">I</forename><surname>Nishino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Mcv</forename><surname>Malicdan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Murayama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Nonaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">K</forename><surname>Hayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Noguchi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Myol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="80" to="83" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b94">
	<analytic>
		<title level="a" type="main">Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 allelic profiles and motifs define clinicopathologic groups in caucasians</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>O'hanlon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Carrick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Arnett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Reveille</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Carrington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Gao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Medicine (Balt)</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="338" to="349" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b95">
	<analytic>
		<title level="a" type="main">Mitochondrial DNA deletions in muscle fibers in inclusion body myositis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Oldfors</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Moslemi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Fyhr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Holme</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">G</forename><surname>Larsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lindberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neuropathol Exp Neurol</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="581" to="587" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b96">
	<analytic>
		<title level="a" type="main">Mitochondrial abnormalities in inclusion-body myositis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Oldfors</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Moslemi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Jonasson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ohlsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kollberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lindberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="S49" to="55" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b97">
	<analytic>
		<title level="a" type="main">Sporadic inclusion body myositis not linked to prion protein codon 129 methionine homozygosity</title>
		<author>
			<persName><forename type="first">M</forename><surname>Orth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Tabrizi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Schapira</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page">1235</biblScope>
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b98">
	<analytic>
		<title level="a" type="main">Influence of UDP-GlcNAc 2-epimerase/ManNAc kinase mutant proteins on hereditary inclusion body myopathy</title>
		<author>
			<persName><forename type="first">J</forename><surname>Penner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">R</forename><surname>Mantey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Elgavish</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ghaderi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cirak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Berger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochemistry</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="2968" to="2977" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b99">
	<analytic>
		<title level="a" type="main">Prevalence of sporadic inclusion body myositis in Western Australia</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Phillips</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Zilko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Mastaglia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Muscle Nerve</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="970" to="972" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b100">
	<analytic>
		<title level="a" type="main">Patterns of muscle involvement in inclusion body myositis: clinical and magnetic resonance imaging study</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Phillips</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Cala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Thickbroom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Melsom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Zilko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Mastaglia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Muscle Nerve</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="1526" to="1534" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b101">
	<analytic>
		<title level="a" type="main">Bcl-2, Bcl-x and Bax expression by immunohistochemistry in inclusion body myositis: a study of 27 cases</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Prayson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Yu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Pathol Lab Med</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="page" from="1326" to="1330" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b102">
	<analytic>
		<title level="a" type="main">The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases</title>
		<author>
			<persName><forename type="first">P</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Campbell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Allcock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Sayer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Garlepp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Kok</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunol Rev</title>
		<imprint>
			<biblScope unit="volume">167</biblScope>
			<biblScope unit="page" from="257" to="274" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b103">
	<analytic>
		<title level="a" type="main">Two major histocompatibility complex haplotypes influence susceptibility to sporadic inclusion body myositis: critical evaluation of an association with HLA-DR3</title>
		<author>
			<persName><forename type="first">P</forename><surname>Price</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Santoso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mastaglia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Garlepp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Kok</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Allcock</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Tissue Antigens</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="575" to="580" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b104">
	<analytic>
		<title level="a" type="main">Beta-amyloid peptide expression is sufficient for myotube death: implications for human inclusion body myopathy</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">W</forename><surname>Querfurth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Suhara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Rosen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Mcphie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Fujio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Tejada</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Cell Neurosci</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="793" to="810" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b105">
	<analytic>
		<title level="a" type="main">Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biologic validation of clinical relevant genes</title>
		<author>
			<persName><forename type="first">R</forename><surname>Raju</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<imprint>
			<biblScope unit="volume">128</biblScope>
			<biblScope unit="page" from="1887" to="1896" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b106">
	<analytic>
		<title level="a" type="main">Absence of upregulated genes associated with protein accumulations in desmin myopathy</title>
		<author>
			<persName><forename type="first">R</forename><surname>Raju</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Muscle Nerve</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="386" to="388" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b107">
	<analytic>
		<title level="a" type="main">Familial inflammatory inclusion body myositis</title>
		<author>
			<persName><forename type="first">B</forename><surname>Ranque-Francois</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Maisonobe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Dion</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Piette</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Chauveheid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Amoura</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Rheum Dis</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="634" to="637" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b108">
	<analytic>
		<title level="a" type="main">Beta-amyloid precursor protein mRNA is increased in inclusion-body myositis muscle</title>
		<author>
			<persName><forename type="first">E</forename><surname>Sarkozi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Alvarez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroreport</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="815" to="818" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b109">
	<analytic>
		<title level="a" type="main">Abnormal accumulation of prion protein mRNA in muscle fibers of patients with sporadic inclusion-body myositis and hereditary inclusion-body myopathy</title>
		<author>
			<persName><forename type="first">E</forename><surname>Sarkozi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Askanas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Engel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">145</biblScope>
			<biblScope unit="page" from="1280" to="1284" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b110">
	<analytic>
		<title level="a" type="main">Distinct interplay between inflammatory and degeneration-associated molecules in sporadic IBM</title>
		<author>
			<persName><forename type="first">J</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Raju</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Salajegheh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Rakocevic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Voss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="A331" to="A338" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b111">
	<analytic>
		<title level="a" type="main">Sporadic inclusion body myositis in Japanese is associated with the MHC ancestral haplotype 52</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Allcock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mastaglia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Nishino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Nonaka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Laing</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuromuscul Disord</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="311" to="315" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b112">
	<analytic>
		<title level="a" type="main">Rimmed vacuoles with betaamyloid and ubiquitinated filamentous deposits in the muscles of patients with long-standing denervation (postpoliomyelitis muscular atrophy): similarities with inclusion body myositis</title>
		<author>
			<persName><forename type="first">C</forename><surname>Semino-Mora</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Pathol</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="1128" to="1133" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b113">
	<analytic>
		<title level="a" type="main">Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians: ethnogeographic influences in the genetics and clinical expression of myositis</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Shamim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Rider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Pandey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>'hanlon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">P</forename><surname>Jara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Samayoa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="1885" to="1893" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b114">
	<analytic>
		<title level="a" type="main">Exons 16 and 17 of the amyloid precursor protein gene in familial inclusion body myopathy</title>
		<author>
			<persName><forename type="first">K</forename><surname>Sivakumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cervenakova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Leon-Monzon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Isaacson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Nagle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Neurol</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="267" to="269" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b115">
	<analytic>
		<title level="a" type="main">The spectrum of familial inclusion body myopathies in 13 families and a description of a quadriceps-sparing phenotype in non-Iranian Jews</title>
		<author>
			<persName><forename type="first">K</forename><surname>Sivakumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="977" to="984" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b116">
	<analytic>
		<title level="a" type="main">An inflammatory, familial, inclusion body myositis with autoimmune features and a phenotype identical to sporadic inclusion body myositis. Studies in three families</title>
		<author>
			<persName><forename type="first">K</forename><surname>Sivakumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Semino-Mora</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="page" from="653" to="661" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b117">
	<analytic>
		<title level="a" type="main">Analysis of genes within the HLA region affecting susceptibility to ulcerative colitis</title>
		<author>
			<persName><forename type="first">K</forename><surname>Sugimura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Asakura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mizuki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Inoue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hibi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Yagita</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Immunol</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="112" to="118" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b118">
	<analytic>
		<title level="a" type="main">Familial inclusion body myositis: a report on two Japanese sisters</title>
		<author>
			<persName><forename type="first">M</forename><surname>Tateyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Saito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Fujihara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Shiga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Takeda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Narikawa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Intern Med</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="1035" to="1038" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b119">
	<analytic>
		<title level="a" type="main">Increased expression of manganese superoxide dismutase is associated with that of nitrotyrosine in myopathies with rimmed vacuoles</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Tsuruta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Furuta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Taniguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yamada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J-I</forename><surname>Kira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Iwaki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Neuropathol (Berl)</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="page" from="59" to="65" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b120">
	<analytic>
		<title level="a" type="main">GNE mutations in an American family with quadriceps-sparing IBM and lack of mutations in s-IBM</title>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">M</forename><surname>Vasconcelos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Raju</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Dalakas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="1776" to="1779" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b121">
	<analytic>
		<title level="a" type="main">Amloidogenic processing of ␤-amyloid precursor protein in intracellular compartments</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Vetrivel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Thinakaran</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="S69" to="S73" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b122">
	<analytic>
		<title level="a" type="main">Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein</title>
		<author>
			<persName><forename type="first">Gdj</forename><surname>Watts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Kovach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Mehta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mumm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Darvish</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pestronk</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="377" to="381" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b123">
	<analytic>
		<title level="a" type="main">GNE mutations causing distal myopathy with rimmed vacuoles with inflammation</title>
		<author>
			<persName><forename type="first">I</forename><surname>Yabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Higashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kikuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sasaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Fuazawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yoshida</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurology</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="384" to="386" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b124">
	<analytic>
		<title level="a" type="main">RAGE and amyloid-beta peptide neurotoxicity in Alzheimer&apos;s disease</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Yan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Roher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">382</biblScope>
			<biblScope unit="page" from="685" to="691" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b125">
	<analytic>
		<title level="a" type="main">Increased expression of the normal cellular isoform of prion protein in inclusion-body myositis, inflammatory myopathies and denervation atrophy</title>
		<author>
			<persName><forename type="first">G</forename><surname>Zanusso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Vattemi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ferrari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tabaton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Pecini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Cavallaro</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain Pathol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="182" to="189" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
